ESCC tumor tissues; adjacent normal esophageal tissues
TE-1; EC9706; Het-1A
cell line-derived xenograft
EGFR (inhibits); PI3K/AKT (inhibits); proliferation (inhibits); migration (inhibits); invasion (inhibits); metastasis (inhibits); EMT (inhibits); apoptosis (promotes); cell cycle (inhibits); ceRNA regulation (other)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Microarray; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Transwell Assay; Wound Healing Assay; In Vivo Animal Model; IHC (Immunohistochemistry); Western Blot; Cohort Study; Survival Analysis; Bioinformatics Analysis
Low circ_0007624 expression was associated with poor prognosis, advanced TNM stage and lymph node metastasis in ESCC patients.
circ_0007624 is down-regulated in ESCC and low expression predicts worse survival. It functions as a tumor suppressor by sponging miR-224-5p, increasing CPEB3 expression, and inactivating EGFR/PI3K/AKT signaling, thereby inhibiting proliferation, metastasis and EMT while promoting apoptosis.
0.8921
Circ_0007624 suppresses the development of esophageal squamous cell carcinoma via targeting miR-224-5p/CPEB3 to inactivate the EGFR/PI3K/AKT signaling.
combined biological and clinical study